OKYO Pharma Limited (OKYO) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

OKYO Pharma Limited (OKYO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $64.8M, listed on NASDAQ, employing roughly 3 people, carrying a beta of -0.05 to the broader market. OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Led by Robert J. Dempsey, public since 2022-05-17.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for OKYO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →